about
Myeloid suppressor cells and immune modulation in lung cancerThe Multifaceted Roles Neutrophils Play in the Tumor MicroenvironmentRestoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinomaGrape seed proanthocyanidins inhibit melanoma cell invasiveness by reduction of PGE2 synthesis and reversal of epithelial-to-mesenchymal transition.Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of NSCLC.Green tea catechins reduce invasive potential of human melanoma cells by targeting COX-2, PGE2 receptors and epithelial-to-mesenchymal transition.TGF-β1 downregulates COX-2 expression leading to decrease of PGE2 production in human lung cancer A549 cells, which is involved in fibrotic response to TGF-β1.Early manifestations of NNK-induced lung cancer: role of lung immunity in tumor susceptibility.Cyclooxygenase-2 knockdown using retinoic acid chalcone (RAC), a promising therapeutic strategy for colon cancerArginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.Therapeutic intervention of proanthocyanidins on the migration capacity of melanoma cells is mediated through PGE2 receptors and β-catenin signaling moleculesThe transcription factor c-Fos coordinates with histone lysine-specific demethylase 2A to activate the expression of cyclooxygenase-2Timosaponin AIII inhibits melanoma cell migration by suppressing COX-2 and in vivo tumor metastasisResveratrol Treatment Inhibits Proliferation of and Induces Apoptosis in Human Colon Cancer Cells.Inflammation and lung carcinogenesis: applying findings in prevention and treatment.Signaling defects in anti-tumor T cellsInflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment.Depletion of cytosolic phospholipase A2 in bone marrow-derived macrophages protects against lung cancer progression and metastasisA cross-talk between NFAT and NF-κB pathways is crucial for nickel-induced COX-2 expression in Beas-2B cellsAssociation of nonsteroidal anti-inflammatory drugs with lung cancer: results from a large cohort studyCollapsin response mediator proteins: Potential diagnostic and prognostic biomarkers in cancers (Review).Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors and Therapeutic Approaches: An Update.EGFR signaling is required for TGF-beta 1 mediated COX-2 induction in human bronchial epithelial cells.Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E₂ and prostaglandin E₂ receptorsArtesunate inhibits the growth and induces apoptosis of human gastric cancer cells by downregulating COX-2Cyclooxygenase-2 induction by arsenite is through a nuclear factor of activated T-cell-dependent pathway and plays an antiapoptotic role in Beas-2B cells.Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma MetastasisIL-10 production in non-small cell lung carcinoma patients is regulated by ERK, P38 and COX-2.Protective effects of cyclooxygenase-2 inhibitors on narrow-band ultraviolet B-irradiated epidermal Ia+ Langerhans cells and Thy-1+ dendritic epidermal T cells in mice.Action of celecoxib on hepatic metabolic changes induced by the Walker-256 tumour in rats.Nickel compounds render anti-apoptotic effect to human bronchial epithelial Beas-2B cells by induction of cyclooxygenase-2 through an IKKbeta/p65-dependent and IKKalpha- and p50-independent pathway.Gallotannin regulates apoptosis and COX-2 expression via Akt and p38kinase pathway in human lung cancer cell line, A549
P2860
Q26823251-14A31608-78F4-495C-B5DA-603DC44B3376Q28241308-536AA3A5-A8B3-4A7E-8DFF-2F19BED8447CQ33646333-F0FBFC40-B0D4-4FFB-8F84-00518A4BF3A6Q33955027-36B0FCD0-455B-4226-B819-06C1A339ACE8Q34003141-D3D598C5-4224-4438-BDC0-08893155192CQ34055550-CA7D0EB3-13F6-44F4-AFD7-DB8473A7598DQ35009383-F0194000-38A4-48A6-B08C-EC0973811074Q35855247-52B5D9A0-7810-4C51-B2C8-8423F3FFA955Q35929848-D63C9795-B3F7-44D6-92BB-1FDF76694284Q36403544-0EF919AA-5B51-4CCF-B764-E9954462511FQ36420150-8FF043F9-C044-4C5D-8E8D-C63D82D20A11Q36544190-4C4E2EC7-9EC1-42DC-B239-B71D4D15E99CQ36622079-2392D818-8C3B-4F0E-8B46-51857D386D7EQ36771532-3021AAFF-E69E-4DED-A4D3-D583557FDB84Q36974700-D58C9D15-5DC3-45DA-A693-3C6E9AC33829Q37063739-42D8F409-EFFF-4222-B009-17E663BF9CCCQ37096361-E75070EB-1433-4DFA-BC7C-22B967AE5055Q37121616-184F7349-D828-49C5-A644-9C0F07621E2DQ37137516-3481CE76-C44B-4517-9E37-6B709FE15EABQ37218443-A394C7C8-7DCF-433C-BE53-844A6B6B66ABQ37719998-27A70D4B-31AF-4CF7-800D-EF80BEDB4BCCQ38669280-E0DDD68E-8A65-4934-B46E-C7751CD5FAA5Q39241053-DC984D00-80DC-4565-A6A4-661B8AD8B980Q39640064-065E9763-879A-46EA-BD6D-0F91FCD766BDQ39868022-C948C314-6272-43C0-B32B-E7D5CB8EB315Q40261258-86F55856-5025-45CA-8092-7798C69DB52EQ42731074-1EECB59D-34F6-46DD-A3FA-CE66AD95F5F0Q42914474-1D17D8D8-373C-4FE8-95E8-3943CE12E517Q46759770-051DF57B-00B0-4587-9B3E-2BD111807BD0Q46970976-4ABA8480-AB29-43D3-BE43-570D53C73BD1Q53341929-3AAB801D-DF06-46C3-B85F-2F3A21654761Q58295079-F226B2E4-DD00-45BE-8EEE-E4E6AF90AEE3
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Multifaceted roles of cyclooxygenase-2 in lung cancer.
@ast
Multifaceted roles of cyclooxygenase-2 in lung cancer.
@en
type
label
Multifaceted roles of cyclooxygenase-2 in lung cancer.
@ast
Multifaceted roles of cyclooxygenase-2 in lung cancer.
@en
prefLabel
Multifaceted roles of cyclooxygenase-2 in lung cancer.
@ast
Multifaceted roles of cyclooxygenase-2 in lung cancer.
@en
P2093
P1476
Multifaceted roles of cyclooxygenase-2 in lung cancer.
@en
P2093
Harnisha Dalwadi
Jenny T Mao
Karen Riedl
Kostyantyn Krysan
Mariam Dohadwala
Mehis Põld
Nathalie Heuze-Vourc'h
Robert Figlin
Robert Strieter
P304
P356
10.1016/J.DRUP.2004.04.003
P577
2004-06-01T00:00:00Z